The latest epilepsy news
Ketamine ‘effective’ for status epilepticus
Grace Wood | The researchers concluded it was “an effective drug with a good response rate”
Epilepsy research
EU introduces valproate measures
Grace Wood | European Medicines Agency announces measures for prescribing valproate medicines
Epilepsy research
Drug developed for rare epilepsies
Grace Wood | Bexicaserin, an epilepsy drug for rare conditions, has been shown to reduce seizures
The latest epilepsy news
Sodium valproate restrictions to begin in January
Grace Wood | New restrictions for sodium valproate come into effect on January 31, 2024. The changes affect men and boys for the first time
The latest epilepsy news
Valproate boxes must now contain safety warnings
Grace Wood | Valproate will now be dispensed in the manufacturer’s original full packaging
The latest epilepsy news
Sanofi sells epilepsy medications to Pharmanovia
Grace Wood | Pharmanovia is a global healthcare company with headquarters in Essex
The latest epilepsy news
EMA updates topiramate guidance
Grace Wood | The measures have been put in place to avoid exposing children to topiramate-containing medicines in the womb
The latest epilepsy news
NHS updates medicine guidance for trusts
Grace Wood | The “optimisation opportunities” ask integrated care boards to focus on 16 priorities
Epilepsy medication
Epilepsy coalition issues valproate statement
A coalition of epilepsy charities has expressed its loss of confidence in the MHRA over proposed changes to the regulatory policy for sodium valproate
Page 3 of 7